Dr. Anders Nyberg
VIENNA– In addition to dramatically increasing the risk of liver cancer more than 68-fold, chronic hepatitis C virus... More
Exercise pumps up chemotherapy completion rates for breast cancer patients
Compared with usual care, a moderate- to high-intensity exercise intervention had beneficial effects on chemotherapy... More
VIDEO: NAFLD increasingly causing U.S. hepatocellular carcinomas
VIENNA – Nonalcoholic fatty liver disease (NAFLD) now stands as the second most common cause of U.S. cases of... More
More physicians support Democratic candidates
Most U.S. physicians who made political contributions during the 2013-2014 congressional election cycle donated to... More
Gardasil vaccination reduces cervical dysplasia in teen years
Vaccination with Gardasil, the quadrivalent human papillomavirus (HPV) vaccine, can reduce cervical dysplasia and... More
Ramucirumab approval expanded to include metastatic colorectal cancer indication
The Food and Drug Administration has expanded approval of the antiangiogenic agent ramucirumab for use in combination... More
Sen. Ron Johnson
WASHINGTON – As the Supreme Court prepares to rule this summer on King v. Burwell, Republican Senators are offering... More
Dr. Krishnansu S. Tewari
CHICAGO – Circulating tumor cells are a prognostic biomarker for overall survival in women with advanced cervical... More
Dr. Martin Reck
GENEVA – The tests widely available today that use a cancer patient’s tumor DNA that circulates in the blood to detect... More
Dr. Edward Garon
Results from KEYNOTE-001 show that not only is the anti-PD-L1 antibody pembrolizumab clinically active in advanced... More
Dr. Ane Gerda Zahl Eriksson
CHICAGO – Sentinel lymph node mapping is a safe, less extensive alternative to lymph node dissection in women with... More
PATRICE WENDLING
SAN FRANCISCO – Reducing factor XI levels with the experimental antisense oligonucleotide FXI-ASO lowered venous thromboembolism rates after total knee arthroplasty without increasing bleeding in a phase II study. Venous thromboembolism (VTE) rate... More »
 
PATRICE WENDLING
SAN FRANCISCO – Combining anti-CD38 monoclonal antibodies with standard antimyeloma therapies proved highly active without excessive toxicity in newly diagnosed as well as relapsed or refractory multiple myeloma in a pair of phase Ib studies. “T... More »
 

News

SARA FREEMAN
VIENNA– In addition to dramatically increasing the risk of liver cancer more than 68-fold, chronic hepatitis C virus (HCV) infection more than doubled or tripled the risk of a host of other solid tumors and hematologic malignancies in a large retro... More »
 

News

JENNIFER KELLY SHEPPHIRD
Analysis of a large cohort of patient tumor samples from four international adjuvant chemotherapy trials confirms the prognostic value of the latest, soon-to-be-published, World Health Organization lung adenocarcinoma classifications, investigators r... More »
 

Policy & Practice Podcast

GREGORY TWACHTMAN
If you thought Medicare physician payments might finally be safe in the wake of SGR repeal, think again. Lawmakers are proposing to cut Medicare payments to help fund the Trade Adjustment Assistance bill, which would help workers displaced by foreign... More »
 

Reimbursement and Management

LUCAS FRANKI
Of all drugs to be released in 2015, the melanoma drug Opdivo (nivolumab) is expected to have the brightest future, according to a report from Thomson Reuters. With sales forecast to reach nearly $5.7 billion by 2019, Opdivo is at the head of a larg... More »
 
Collin T Zimmerman et al
The recent approval by the US Food and Drug Administration of the oral, fixed-dose combination of netupitant and palonosetron (NEPA) offers a single pill alternative to multiagent antiemetic regimens that are the current standard of care for the prev... More »
 
Debra Patt, MD, MPH, MBA
As I write this, the permanent fix to the sustainable growth rate (SGR) has been passed overwhelmingly in the US House of Representatives. The Senate has adjourned for spring break so has yet to vote on the fix, but there is optimism that it will pas... More »
 
Suzanne C Danhauer et al
Background Treatment-related symptoms and decreased health-related quality of life (HRQoL) frequently occur during chemotherapy for breast cancer. Although research findings suggest that yoga can reduce symptoms and improve HRQoL after treatment, pot... More »
 
Kim A Margolin et al
Background Ipilimumab was approved in 2011 by the US Food and Drug Administration in 2011 for the treatment of unresectable or metastatic (advanced) melanoma, although pivotal data using the approved 3 mg/kg monotherapy q3w × 4 were available only f... More »